Accueil/Actions/ESPR

ESPR

USD

Esperion Therapeutics Inc. Common Stock

$2.850+0.000 (0.000%)

Prix en Temps Réel

Healthcare

Drug Manufacturers - Specialty & Generic

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$2.850

Haut

$2.970

Bas

$2.800

Volume

5.35M

Fondamentaux de l'Entreprise

Capitalisation Boursière

660.1M

Industrie

Drug Manufacturers - Specialty & Generic

Pays

United States

Statistiques de Trading

Volume Moyen

6.69M

Bourse

NGM

Devise

USD

Intervalle sur 52 Semaines

Bas $0.69Actuel $2.850Haut $3.94

Actualités Connexes

4 nov. 2025 · 13:00

GlobeNewswire

Esperion Appoints Industry Veteran John Harlow as Chief Commercial Officer

– Brings Extensive Executive Leadership Driving Commercial Strategies That Enhance Sales and Marketing Performance – ANN ARBOR, Mich., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced the

Esperion Appoints Industry Veteran John Harlow as Chief Commercial Officer

3 nov. 2025 · 13:00

GlobeNewswire

Esperion to Participate in Jefferies Global Healthcare Conference - London

ANN ARBOR, Mich., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced that the company will present at the Jefferies Global Healthcare Conference – London on November 18, 2025, at 8:00 a.m. GMT

27 oct. 2025 · 12:00

GlobeNewswire

Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025

ANN ARBOR, Mich., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced that an oral presentation and a poster presentation have been accepted for presentation at the AHA Scientific Sessions 2025 in